{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:26:31Z","timestamp":1780367191406,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jcv.2021.104822","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T07:49:29Z","timestamp":1618472969000},"page":"104822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Clinical validation of a quantitative HIV-1 DNA droplet digital PCR assay: Applications for detecting occult HIV-1 infection and monitoring cell-associated HIV-1 dynamics across different subtypes in HIV-1 prevention and cure trials"],"prefix":"10.1016","volume":"139","author":[{"given":"Laura","family":"Powell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adit","family":"Dhummakupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8062-271X","authenticated-orcid":false,"given":"Lilly","family":"Siems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolly","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Le Duff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Uprety","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0540-3274","authenticated-orcid":false,"given":"Joseph","family":"Szewczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1684-2013","authenticated-orcid":false,"given":"Eleni","family":"Nastouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Persaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jcv.2021.104822_bib0005","first-page":"840","article-title":"Difficulties in assigning human immunodeficiency virus-1 infection and seroreversion status in a cohort of HIV-exposed in children using serologic criteria established by the Centers for Disease Control and Prevention","volume":"93","author":"Simpson","year":"1994","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.jcv.2021.104822_bib0010","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1128\/CMR.5.3.238","article-title":"Laboratory methods for early detection of human immunodeficiency virus type 1 in newborns and infants","volume":"5","author":"Sison","year":"1992","journal-title":"Clin. Microbiol. Rev."},{"issue":"Suppl 1","key":"10.1016\/j.jcv.2021.104822_bib0015","first-page":"S1","article-title":"Challenges in the early infant HIV diagnosis and treatment cascade","volume":"2020","author":"Mofenson","year":"1999","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jcv.2021.104822_bib0020","series-title":"Diagnosis of HIV Infection in Infants and Children","author":"WHO","year":"2010"},{"issue":"12","key":"10.1016\/j.jcv.2021.104822_bib0025","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jamapediatrics.2014.1560","article-title":"Pediatric HIVACS. Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescents","volume":"168","author":"Persaud","year":"2014","journal-title":"JAMA Pediatr."},{"issue":"5","key":"10.1016\/j.jcv.2021.104822_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(20)30100-4","article-title":"The HIV-1 antibody response: a footprint of the viral reservoir in children vertically infected with HIV","volume":"7","author":"Palma","year":"2020","journal-title":"Lancet HIV"},{"issue":"19","key":"10.1016\/j.jcv.2021.104822_bib0035","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa1302976","article-title":"Absence of detectable HIV-1 viremia after treatment cessation in an infant","volume":"369","author":"Persaud","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2021.104822_bib0040","article-title":"Human Immunodeficiency Virus (HIV)-Antibody Repertoire Estimates Reservoir Size and Time of Antiretroviral Therapy Initiation in Virally Suppressed Perinatally HIV-Infected Children","author":"Rocca","year":"2018","journal-title":"J. Pediatric Infect. Dis. Soc."},{"issue":"3","key":"10.1016\/j.jcv.2021.104822_bib0045","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/INF.0000000000000570","article-title":"Rapid viral rebound after 4 years of suppressive therapy in a seronegative HIV-1 infected infant treated from birth","volume":"34","author":"Butler","year":"2015","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"7","key":"10.1016\/j.jcv.2021.104822_bib0050","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/QAD.0000000000000178","article-title":"Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children","volume":"28","author":"Ananworanich","year":"2014","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.jcv.2021.104822_bib0055","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/QAD.0000000000001739","article-title":"Janse van Rensburg A, Laughton B, Mellors JW, Cotton MF, van Zyl GU. Rapid decline of HIV-1 DNA and RNA in infants starting very early antiretroviral therapy may pose a diagnostic challenge","volume":"32","author":"Veldsman","year":"2018","journal-title":"AIDS"},{"issue":"15","key":"10.1016\/j.jcv.2021.104822_bib0060","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1097\/QAD.0b013e32835705bf","article-title":"False-negative post-18-month confirmatory HIV tests in HIV DNA PCR-positive children: a retrospective analysis","volume":"26","author":"Garcia-Prats","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.jcv.2021.104822_bib0065","series-title":"Transmission PoToPWwHIaPoP. Recommendations for Use of Antiretroviral Drugs in Transmission in the United States","year":"2020"},{"issue":"520","key":"10.1016\/j.jcv.2021.104822_bib0070","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax7350","article-title":"Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile","volume":"11","author":"Garcia-Broncano","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.jcv.2021.104822_bib0075","doi-asserted-by":"crossref","first-page":"e1002417","DOI":"10.1371\/journal.pmed.1002417","article-title":"HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: an observational study","volume":"14","author":"Henrich","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.jcv.2021.104822_bib0080","article-title":"Continuous prophylactic ARV\/ART since birth reduces seeding and persistence of the viral reservoir in vertically HIV-infected children","author":"Massanella","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2021.104822_bib0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-1022-1","article-title":"Infection B-HDCtCH-. Recommendations for measuring HIV reservoir size in cure-directed clinical trials","author":"Abdel-Mohsen","year":"2020","journal-title":"Nat. Med."},{"issue":"134","key":"10.1016\/j.jcv.2021.104822_bib0090","article-title":"Measuring the success of HIV-1 cure strategies","volume":"10","author":"Thomas","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"22","key":"10.1016\/j.jcv.2021.104822_bib0095","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1021\/ac202028g","article-title":"High-throughput droplet digital PCR system for absolute quantitation of DNA copy number","volume":"83","author":"Hindson","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jcv.2021.104822_bib0100","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa270","article-title":"Kinetics of plasma HIV rebound in the era of modern antiretroviral therapy","author":"Sneller","year":"2020","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.jcv.2021.104822_bib0105","doi-asserted-by":"crossref","first-page":"e55943","DOI":"10.1371\/journal.pone.0055943","article-title":"Highly precise measurement of HIV DNA by droplet digital PCR","volume":"8","author":"Strain","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jcv.2021.104822_bib0110","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1038\/s41598-017-02217-x","article-title":"Droplet Digital PCR versus qPCR for gene expression analysis with low abundant targets: from variable nonsense to publication quality data","volume":"7","author":"Taylor","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.jcv.2021.104822_bib0115","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1073\/pnas.86.7.2365","article-title":"Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone","volume":"86","author":"Folks","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.jcv.2021.104822_bib0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12977-016-0325-2","article-title":"HIV integration sites in latently infected cell lines: evidence of ongoing replication","volume":"14","author":"Symons","year":"2017","journal-title":"Retrovirology"},{"key":"10.1016\/j.jcv.2021.104822_bib0125","series-title":"Stata 16 Base Reference Manual","author":"StataCorp","year":"2019"},{"key":"10.1016\/j.jcv.2021.104822_bib0130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jviromet.2014.02.020","article-title":"Low copy target detection by Droplet Digital PCR through application of a novel open access bioinformatic pipeline,\u2019 definetherain\u2019","volume":"202","author":"Jones","year":"2014","journal-title":"J. Virol. Methods"},{"issue":"19","key":"10.1016\/j.jcv.2021.104822_bib0135","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1007\/s00216-015-8773-4","article-title":"ddpcRquant: threshold determination for single channel droplet digital PCR experiments","volume":"407","author":"Trypsteen","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"issue":"26","key":"10.1016\/j.jcv.2021.104822_bib0140","doi-asserted-by":"crossref","first-page":"6513","DOI":"10.1007\/s00216-014-8084-1","article-title":"Optimising droplet digital PCR analysis approaches for detection and quantification of bacteria: a case study of fire blight and potato brown rot","volume":"406","author":"Dreo","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"issue":"11","key":"10.1016\/j.jcv.2021.104822_bib0145","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/cid\/cix192","article-title":"Human immunodeficiency virus type 1 DNA decay dynamics with early, long-term virologic control of perinatal infection","volume":"64","author":"Uprety","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.jcv.2021.104822_bib0150","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25368","article-title":"HIV-1 DNA decay is faster in children who initiate ART shortly after birth than later","volume":"22","author":"Veldsman","year":"2019","journal-title":"J. Int. AIDS Soc."},{"issue":"8","key":"10.1016\/j.jcv.2021.104822_bib0155","first-page":"2258","article-title":"HIV-1 DNA decay dynamics in early treated individuals: practical considerations for clinical trial design","volume":"75","author":"Bayon-Gil","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"issue":"10","key":"10.1016\/j.jcv.2021.104822_bib0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205579","article-title":"Impact of the time to achieve viral control on the dynamics of circulating HIV-1 reservoir in vertically infected children with long-term sustained virological suppression: A longitudinal study","volume":"13","author":"Moragas","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jcv.2021.104822_bib0165","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/cid\/ciu585","article-title":"HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy","volume":"59","author":"Besson","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.jcv.2021.104822_bib0170","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.4156","article-title":"Defective proviruses rapidly accumulate during acute HIV-1 infection","volume":"22","author":"Bruner","year":"2016","journal-title":"Nat. Med."},{"issue":"7742","key":"10.1016\/j.jcv.2021.104822_bib0175","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-019-0898-8","article-title":"A quantitative approach for measuring the reservoir of latent HIV-1 proviruses","volume":"566","author":"Bruner","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jcv.2021.104822_bib0180","article-title":"Capitalizing on post-exposure ARV prophylaxis to restrict seeding of the HIV reservoir","author":"Dhummakupt","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2021.104822_bib0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-med-041217-013717","article-title":"Long-acting HIV drugs for treatment and prevention","volume":"70","author":"Gulick","year":"2019","journal-title":"Annu. Rev. Med."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653221000895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653221000895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:14:11Z","timestamp":1761362051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653221000895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":37,"alternative-id":["S1386653221000895"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2021.104822","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.09.29.20200154","asserted-by":"object"}]},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical validation of a quantitative HIV-1 DNA droplet digital PCR assay: Applications for detecting occult HIV-1 infection and monitoring cell-associated HIV-1 dynamics across different subtypes in HIV-1 prevention and cure trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2021.104822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104822"}}